NewAmsterdam Pharma Company N.V. (NAMS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$29.35
Day's range
$30.8

NewAmsterdam Pharma Company NV Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2026 16.94 M $542.37 M   0.00% 14.81%
CAPITAL WORLD INVESTORS 05/13/2026 11.11 M $355.60 M   11.27% 9.71%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 9.55 M $305.70 M   0.00% 8.35%
FCPM III SERVICES B.V. 05/15/2026 9.20 M $294.46 M   0.00% 8.04%
FMR LLC 05/15/2026 8.77 M $280.59 M   36.69% 7.66%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 05/15/2026 7.31 M $233.88 M   0.00% 6.39%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 5.12 M $163.76 M   1.64% 4.47%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 4.26 M $136.52 M   2.40% 3.73%
VIKING GLOBAL INVESTORS LP 05/15/2026 4.20 M $134.56 M   0.00% 3.67%
DUQUESNE FAMILY OFFICE LLC 05/15/2026 3.07 M $98.28 M   0.00% 2.68%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 2.83 M $90.64 M   2.00% 2.48%
JENNISON ASSOCIATES LLC 05/06/2026 2.75 M $88.04 M   -21.17% 2.40%
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 04/21/2026 2.67 M $85.60 M   -6.81% 2.34%
JANUS HENDERSON GROUP PLC 05/18/2026 2.26 M $72.25 M   -3.53% 1.97%
WESTFIELD CAPITAL MANAGEMENT CO LP 05/11/2026 2.20 M $70.52 M   100.00% 1.93%
MAVERICK CAPITAL LTD 05/15/2026 2.19 M $69.99 M   15.42% 1.91%
GOLDMAN SACHS GROUP INC 05/15/2026 1.95 M $62.30 M   12.79% 1.70%
CAPITAL INTERNATIONAL INVESTORS 05/13/2026 1.44 M $46.13 M   -30.13% 1.26%
ALLIANCEBERNSTEIN L.P. 05/15/2026 1.20 M $42.07 M   -7.81% 1.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 1.11 M $35.42 M   -21.33% 0.97%
CASTLE HOOK PARTNERS LP 05/15/2026 1.04 M $33.37 M   -3.91% 0.91%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2026 957.44 K $30.65 M   440.88% 0.84%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 950.00 K $30.41 M   -5.00% 0.83%
BLACKROCK, INC. 05/13/2026 886.62 K $28.38 M   4.33% 0.78%
JPMORGAN CHASE & CO 05/13/2026 884.23 K $25.93 M   -11.58% 0.77%
BANK OF AMERICA CORP /DE/ 05/18/2026 847.09 K $27.12 M   84.39% 0.74%
ABRDN PLC 04/29/2026 837.01 K $26.79 M   14.74% 0.73%
UBS GROUP AG 05/05/2026 794.98 K $25.45 M   -11.61% 0.69%
FRANKLIN RESOURCES INC 05/13/2026 770.16 K $24.65 M   0.14% 0.67%
AMERIPRISE FINANCIAL INC 05/15/2026 753.05 K $24.11 M   394.56% 0.66%
WOODLINE PARTNERS LP 05/15/2026 752.31 K $24.08 M   0.14% 0.66%
TIMESSQUARE CAPITAL MANAGEMENT, LLC 05/07/2026 751.99 K $24.07 M   -8.55% 0.66%
CITADEL ADVISORS LLC 05/15/2026 712.06 K $22.79 M   12.09% 0.62%
NWI MANAGEMENT LP 06/01/2026 702.00 K $22.47 M   0.00% 0.61%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 600.00 K $19.21 M   33.33% 0.52%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 588.79 K $18.85 M   5.67% 0.51%
FIRST TURN MANAGEMENT, LLC 05/15/2026 558.34 K $17.87 M   -37.51% 0.49%
MORGAN STANLEY 05/15/2026 555.76 K $17.79 M   4.31% 0.49%
AMERICAN CENTURY COMPANIES INC 05/15/2026 519.46 K $16.63 M   -13.91% 0.45%
ARTIA GLOBAL PARTNERS LP 05/15/2026 503.94 K $16.13 M   0.00% 0.44%
HANDELSBANKEN FONDER AB 04/28/2026 418.90 K $13.41 M   0.75% 0.37%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 408.49 K $13.08 M   136.22% 0.36%
BANK OF NEW YORK MELLON CORP 05/05/2026 378.80 K $12.13 M   -3.32% 0.33%
DECHENG CAPITAL LLC 05/13/2026 325.06 K $10.41 M   -45.10% 0.28%
SLATE PATH CAPITAL LP 05/15/2026 319.00 K $10.21 M   0.00% 0.28%
MILLENNIUM MANAGEMENT LLC 05/15/2026 303.85 K $9.73 M   19.35% 0.27%
EVERSEPT PARTNERS, LP 05/15/2026 285.76 K $9.15 M   -32.09% 0.25%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 285.29 K $9.13 M   7.57% 0.25%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 275.00 K $8.80 M   0.00% 0.24%
05/07/2026 272.65 K $8.73 M   100.00% 0.24%

NewAmsterdam Pharma Company NV institutional Ownership - FAQ's

During the previous two years, 207 institutional investors and hedge funds held shares of NewAmsterdam Pharma Company NV. The most heavily invested institutionals were:

Frazier Life Sciences Management, L.P.: 16.94 M

Capital World Investors: 11.11 M

RA CAPITAL MANAGEMENT, L.P.: 9.55 M

FCPM III SERVICES B.V.: 9.2 M

FMR LLC: 8.77 M

Bain Capital Life Sciences Investors, LLC: 7.31 M

108.06% of NewAmsterdam Pharma Company NV stock is owned by institutional investors.

Institutional investors have bought a total of 123.77 M shares in the last 24 months. This purchase volume represents approximately $3.81 B in transactions.